Nuwiq® (Antihemophilic Factor, Recombinant, B-Domain deleted, simoctocog alfa)
Nuwiq® is indicated for the treatment and prophylaxis of bleeding in patients of all ages suffering with hemophilia A (congenital factor VIII deficiency).Nuwiq® is also indicated for the peri-operative treatment of hemophilia A patients.
Patient Resources
Nuwiq® storage information, patient brochure, reconstitution guide and cooler bag.
Safety Information
Important safety information, warnings, precautions and how to report suspected adverse events.
